Let’s talk about something that quietly robs millions of Australians of their hard-earned money—without them even realizing it. Imagine paying three times more for a hip replacement than someone in France, just because of a bureaucratic quirk buried in a 10,000-item list. That’s the reality of Australia’s medical device pricing system, and it’s a story of political compromise, corporate influence, and a broken feedback loop between policy and public interest. I’ve spent years dissecting healthcare systems globally, and this one feels like a masterclass in how not to design a fair market.
The Prescribed List, a government-mandated price schedule for medical devices, is the linchpin of this mess. It dictates what private health insurers must pay hospitals for everything from pacemakers to surgical staples. The kicker? These prices are often 7–358% higher than what public hospitals pay for the exact same products. That’s not a typo. It’s a deliberate policy choice made in 2022, when then-Health Minister Greg Hunt struck a deal with the medical device industry. The bureaucrats in his department warned him it would ‘predominantly benefit industry’—but he went ahead anyway. And here we are, four years later, with the system still intact, even as private health premiums soar and patients foot the bill.
What makes this particularly fascinating is the absurdity of the logic. Why would the government set a price floor for private patients that’s artificially high? It’s like telling a restaurant chain they must charge customers double what a food truck pays for ingredients, just because the truck is ‘public’ and the chain is ‘private.’ The result? Private insurers subsidize multinational corporations, while consumers get stuck with inflated costs. Stephen Duckett, a former health department chief, calls it a ‘legalized transfer of wealth’—a phrase that makes me want to throw a dictionary at a politician. If you take a step back, this isn’t just about prices; it’s about power. Who gets to decide what’s fair? And who profits when the answer is ‘the same people who fund political campaigns’?
The numbers are staggering. Last year, private health funds shelled out $2.52 billion for medical devices—a 3.2% increase despite a mere 1.8% rise in hospital admissions. Meanwhile, the government’s own review admits that even after price cuts, Australia’s rates remain ‘significantly higher’ than in New Zealand, the UK, and France. The Medical Technology Association of Australia, which lobbied for these prices, argues that comparing systems is unfair. But here’s the thing: if your argument hinges on ‘unique regulatory environments,’ you’re not defending fairness—you’re defending a status quo that’s clearly rigged.
And let’s not forget the political theater. Hunt claims his 2022 deal ensured ‘patient access to breakthrough technology’ while securing ‘structural savings.’ But when the Department of Health itself told his successor, Mark Butler, that the agreement ‘was not drafted or negotiated by the department,’ it’s hard not to see this as a textbook case of backroom deals gone rogue. Butler, instead of dismantling the mess, greenlit it. That’s not leadership—it’s a tacit admission that the system is too entrenched to fix. What this really suggests is that both major parties are complicit in a gravy train that’s bleeding consumers dry.
The industry’s response is equally telling. When asked about price disparities, executives insist that insurers ‘simply pocket the difference’ instead of lowering premiums. But here’s the deeper implication: if private hospitals and device manufacturers are making billions off this system, why would they want to disrupt it? It’s a self-perpetuating cycle. The more Australians pay, the more profits flow to the same players. It’s a Ponzi scheme dressed up as healthcare reform.
So where do we go from here? The government’s own review called for ‘international benchmarking’ to align prices with global standards. But that’s easier said than done. Reforming this system would require political courage—something neither Hunt nor Butler seems to possess. Until then, Australians will keep paying a premium for a privilege that’s anything but fair. And honestly? I’m tired of watching policymakers play favorites with our health dollars while the rest of us pick up the tab.
